Business & Finance
Bexion Pharmaceuticals names new director
24 May 2019 - Bexion Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, announced yesterday that it has named Bob Savage, MBA as its director.Savage brings to the Bexion Board more than ...
Selvita incurs higher net loss of USD2.2m in Q1 2019
22 May 2019 - Oncology company Selvita (WSE:SLV) stated on Tuesday that it recorded a net loss (EBITDA excluding IFRS16 impact) of USD2.2m for the first quarter ended 31 March 2019.This is a decline i...
Compugen incurs net loss of USD8.4m for Q1 2019
21 May 2019 - Cancer immunotherapy company Compugen Ltd (NASDAQ:CGEN) disclosed on Monday that it recorded a net loss of USD8.4m (USD0.14 per basic and diluted share) for the first quarter ended 31 Ma...
BioArctic to receive EUR15m milestone payment from Eisai under collaboration regarding BAN2401 confirmatory phase 3 study
21 May 2019 - BioArctic AB (STO:BIOAB), a Swedish research-based biopharmaceutical company, announced on Monday that it will receive a milestone payment of EUR15m from its partner Eisai for the achiev...
RaySearch Laboratories AB announces Proton Therapy Center Czech (Prague PTC) as first Czech clinic to order RayStation
20 May 2019 - Medical technology company RaySearch Laboratories AB (RaySearch) (STO:RAYB) announced on Friday that Proton Therapy Center Czech (Prague PTC) has selected RayStation as its sole treatmen...
Celgene Corp. Announces Pomalyst Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma
...